
Opinion|Videos|September 4, 2024
PSMA PET vs. Gallium-Based PET: Navigating NCCN Guidelines in Prostate Cancer Imaging
Author(s)Jaideep S. Sohi, MD, Jeremie Calais, MD
Jaideep Sohi, MD, and Jeremie Calais, MD, examine the comparative merits of PSMA PET and Gallium-Based PET while exploring the application of NCCN Guidelines in prostate cancer imaging protocols.
Advertisement
Episodes in this series
Video content above is prompted by the following:
- What are the NCCN Guidelines' recommendations for gallium-based versus non-gallium-based PET agents in prostate cancer imaging, and how does PSMA PET imaging impact prostate cancer care in your view?
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Diagnostic Imaging
1
What New Prospective Research Reveals About (177Lu)Lu-PSMA-I&T for Patients with mCRPC
2
PET Radiotracer Gets FDA Breakthrough Therapy Designation for Tumor Hypoxia Detection in HPV-Positive Oropharyngeal Carcinoma
3
The Reading Room Podcast: Assessing the Current Landscape of AI and Reimbursement in Radiology, Part 1
4
Study: Chest CT AI Software Facilitates Nearly 15 Percent Reduction in Reporting Time
5










